Ninepoint Partners LP Johnson & Johnson Transaction History

Ninepoint Partners LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$161.33 - $179.52 $428,492 - $476,805	2,656 New	2,656 $434,000
Q2 2022 Jul 26, 2022	SELL	$168.19 - $186.01 $447,721 - $495,158	-2,662 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$158.14 - $179.59 $420,968 - $478,068	2,662 New	2,662 $472,000
Q4 2021 Feb 07, 2022	SELL	$155.93 - $173.01 $446,271 - $495,154	-2,862 Closed	0 $0
Q2 2021 Aug 09, 2021	BUY	$159.48 - $171.07 $15,788 - $16,935	99 Added 3.58%	2,862 $471,000
Q1 2021 May 07, 2021	BUY	$153.07 - $170.48 $422,932 - $471,036	2,763 New	2,763 $454,000
Q4 2020 Jan 28, 2021	SELL	$137.11 - $157.38 $361,421 - $414,853	-2,636 Closed	0 $0
Q3 2020 Oct 15, 2020	BUY	$140.38 - $153.83 $38,744 - $42,457	276 Added 11.69%	2,636 $392,000
Q2 2020 Jul 30, 2020	BUY	$128.81 - $155.51 $303,991 - $367,003	2,360 New	2,360 $332,000

4,239

1.7B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Ninepoint Partners LP, based on Form 13F filings with the SEC.

Stay updated on Ninepoint Partners LP with notifications on news.